System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

François Pattou is an expert in Endocrinology at Centre Hospitalier Universitaire de Lille (France). As of October 2026, ScienceLeadR ranks François Pattou in the top 1% of experts worldwide for Islets of Langerhans Transplantation, Obesity and Overweight. François Pattou has authored 816 publications, the most recent in 2026, and is an investigator in 26 clinical trials, 4 of them ongoing. SLR score: 2,792 (community average: 125). How the SLR is computed.

LeadR Profile

François Pattou Centre Hospitalier Universitaire de Lille France
2 792 ScienceLeadR Reputation 2792

Unlock

Register Login
Network Map

Endocrinology

Subspecialties: Surgery - Gastroenterology - Nutrition

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1993 - 2026
Source: PubMed

Université Catholique de Lille

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 816

Citations

Citations: 43 441 1st author: 27 Last author: 166 Unique author: 5

Main journals

Diabetes Metab 74
Ann Endocrinol (Paris) 55
Diabetes 27
Ann Surg 23
Diabetologia 21

Best Journals

Lancet Diabetes Endocrinol 9
Nat Med 4
Lancet 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Redox shielding unlocks damage-free photopolymerization for GelMA 3D co-cultures mimicking pancreatic tumor complexity.
PMID 42926891 — cells, acetylcysteine, neoplasms, organoids, stromal cells, tissues		Biomater Biosyst20260
New Obesity Definition and Clinical Obesity Prevalence for Global Metabolic Bariatric Surgery.
PMID 42579277 — cross-sectional studies, classification, adiposity, clinical medicine, bariatric surgery, prevalence, obesity, postoperative complications		JAMA Netw Open20261
The circadian clock controls hepatic stellate cell activation via a BMAL1/CK1ε/REV-ERBα/transgelin signaling pathway.
PMID 42479835 — liver diseases, cells, genes, hepatic stellate cells, fibrosis, circadian rhythm, liver, circadian clocks, genes, rev, therapeutics		Proc Natl Acad Sci U S A20261
Minimally invasive pancreatectomy with mesentericoportal venous resection: Results from a French national cohort.
PMID 42414185 — liver diseases, mortality, blood, operative time, morbidity, pancreatectomy		HPB (Oxford)20260
Decision tree-based prediction of 5-year weight trajectories after bariatric surgery in adolescents and young adults: a retrospective cohort study from France and Sweden.
PMID 42387143 — cohort studies, adolescent, bariatric surgery, obesity, weight loss, body-weight trajectory		Int J Obes (Lond)20260

Clinical Studies 26

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 11 Study Director: 2

By phase:

N/A 17
Phase 3 4
Phase 1/Phase 2 2
Phase 4 2
Phase 2 1

By status:

Completed 13
Recruiting 7
Unknown 3
Terminated 2
Active not recruiting 1

By type:

Interventional 17
Observational 9

By Monocentric/Multicentric:

monocentric 12
multicentric2to4 4
multicentric5to9 5
multicentricup10 5

Main Topics

Cohort/Consortium Investigators 5

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
5 and 7 year Follow up of the YOMEGA Trial Cohort
NCT05549271 — safety, gastric bypass, bariatric surgery, obesity, ligaments		N/ARecruiting2022
Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
NCT05116072 — diabetes mellitus, transplantation, autologous, fistula, laboratories, safety, muscles, absenteeism, pancreaticoduodenectomy, neoplasms, adenocarcinoma, drug therapy, solutions, islets of langerhans transplantation, pancreas, chemotherapy, adjuvant, duodenum, biological therapy, pancreatic fistula, transplantation, catheters, pancreatectomy, surgeons, chemotherapy		Phase 1/Phase 2Recruiting2022
A Safety Tolerability and Efficacy Study of VX 880 and VX 017 in Participants With Type 1 Diabetes
NCT04786262 — diabetes mellitus, cells, islets of langerhans, safety, portal vein, therapeutics, hypoglycemic agents, hypoglycemia, veins, diabetes mellitus, type 1		Phase 3Recruiting2021
Monitoring the Weight Evolution Using a Connected Scale
NCT04639778 — bariatric surgery		N/ARecruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS